What it’s worthwhile to know concerning the coronavirus proper now

Dec 15 (Reuters) – This is what it’s worthwhile to know concerning the coronavirus proper now:

COVID-19 vaccines could also be much less efficient in opposition to Omicron – WHO

Preliminary proof signifies that COVID-19 vaccines could also be much less efficient in opposition to an infection and transmission linked to the Omicron coronavirus variant, which additionally carries a better danger of reinfection, the World Well being Group stated on Wednesday.

The WHO, in its weekly epidemiological replace, stated that extra knowledge was wanted to higher perceive the extent to which Omicron could evade immunity derived from both vaccines or earlier an infection. learn extra

EU regulator backs J&J booster dose for adults

The European Union’s drug regulator on Wednesday beneficial {that a} booster dose of Johnson & Johnson’s COVID-19 shot could also be given not less than two months after a primary dose in individuals aged 18 years and older, because the bloc battles surging infections.

The European Medicines Company stated its suggestion to permit J&J booster doses follows knowledge that confirmed the extra shot led to an increase in antibodies in opposition to the COVID-causing SARS-CoV-2 coronavirus. learn extra

Germany’s vaccine deliveries to drop sharply in Q1

COVID-19 vaccine deliveries into Germany will drop sharply within the first quarter of subsequent yr, the well being ministry stated on Wednesday, denying a report that the shortfall would attain 60 million doses.

The shortfall, which threatens to undermine the nation’s try to regulate a quickly spreading fourth wave of infections, covers first, second and boosters pictures.

German police stated on Wednesday that they had uncovered a plot by anti-vaccination activists in Saxony to homicide the jap German state’s premier, including to considerations about more and more violent protests over plans for necessary vaccinations. learn extra

Poland’s every day COVID loss of life toll hits fourth wave report

Poland’s every day loss of life toll from COVID-19 through the fourth wave of the pandemic has climbed to a report 669, the well being ministry stated on Wednesday, because the nation battles excessive an infection charges with tighter restrictions.

“That is the impact of those final weeks, when the variety of circumstances has amassed. They’re primarily unvaccinated individuals,” authorities spokesman Piotr Muller instructed non-public broadcaster Radio Zet earlier. learn extra

S.Korea considers tightening COVID-19 guidelines

South Korea warned on Wednesday it could reinstate stricter social distancing curbs because it posted a brand new report every day coronavirus tally resulting from a persistent spike in breakthrough infections amongst these vaccinated and critical circumstances.

The Korea Illness Management and Prevention Company posted 7,850 circumstances for Tuesday, with the variety of sufferers in critical situation additionally reaching a recent excessive at 964. learn extra

Australia re-opens borders to non-citizens

Australia on Wednesday reopened borders to vaccinated expert migrants and overseas college students after an almost two-year ban on their entry, in a bid to spice up an financial system hit by stop-start lockdowns.

The emergence of the Omicron variant pressured officers to delay the reopening of worldwide journey by two weeks after well being officers sought a pause to get extra data. learn extra

Sanofi, GSK delay knowledge on vaccine booster candidate

Sanofi and GlaxoSmithKline stated on Wednesday they anticipated knowledge from late-stage scientific trials of the booster dose of their COVID-19 vaccine candidate within the first quarter, as a substitute of this yr, one other delay for the potential shot. learn extra

Register now for FREE limitless entry to reuters.com

Compiled by Linda Noakes; modifying by Barbara Lewis

Our Requirements: The Thomson Reuters Belief Ideas.

Previous post US to increase China blacklist by 8 extra firms
Next post Regent Ron Weiser provides $30 million to UM for prostate most cancers middle